| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
1,405 |
757 |
$995K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,005 |
4,168 |
$350K |
| 80050 |
General health panel |
929 |
867 |
$179K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,166 |
2,817 |
$136K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,110 |
1,626 |
$65K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
391 |
376 |
$64K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
426 |
383 |
$63K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,339 |
1,995 |
$58K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,040 |
1,318 |
$57K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
809 |
744 |
$48K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,742 |
1,420 |
$27K |
| 80053 |
Comprehensive metabolic panel |
4,984 |
4,227 |
$26K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,825 |
1,524 |
$22K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,186 |
1,417 |
$22K |
| 71046 |
Radiologic examination, chest; 2 views |
835 |
756 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,007 |
954 |
$20K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,132 |
1,018 |
$20K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
534 |
455 |
$17K |
| 87631 |
|
124 |
115 |
$15K |
| 81001 |
|
2,345 |
2,081 |
$15K |
| 85027 |
|
216 |
194 |
$14K |
| 80306 |
|
154 |
145 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,173 |
1,042 |
$11K |
| 87081 |
|
175 |
170 |
$10K |
| 80061 |
Lipid panel |
814 |
787 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
532 |
345 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
326 |
294 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
830 |
672 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
122 |
114 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
568 |
526 |
$4K |
| 87070 |
|
74 |
71 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
39 |
38 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
399 |
359 |
$2K |
| 87186 |
|
97 |
91 |
$2K |
| 84439 |
|
155 |
146 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,443 |
1,251 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
127 |
111 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
321 |
240 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
163 |
155 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
120 |
108 |
$1K |
| 84484 |
|
1,273 |
1,059 |
$1K |
| 86140 |
|
1,829 |
1,600 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
148 |
117 |
$1K |
| 85610 |
|
248 |
198 |
$1K |
| 83735 |
|
573 |
483 |
$969.05 |
| 82607 |
|
123 |
123 |
$879.62 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
16 |
$847.98 |
| 83690 |
|
1,124 |
1,010 |
$841.66 |
| 83605 |
|
1,525 |
1,277 |
$528.25 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
16 |
$509.39 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
373 |
332 |
$506.27 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
39 |
37 |
$401.55 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
67 |
66 |
$284.20 |
| 83655 |
|
13 |
13 |
$193.21 |
| 85379 |
|
163 |
149 |
$140.03 |
| 87040 |
|
32 |
25 |
$39.78 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
39 |
38 |
$33.44 |
| 84703 |
|
231 |
211 |
$27.61 |
| 82728 |
|
29 |
28 |
$23.99 |
| 85651 |
|
119 |
97 |
$20.36 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
533 |
503 |
$16.28 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
12 |
$5.50 |
| 84100 |
|
168 |
152 |
$1.21 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
14 |
12 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
30 |
28 |
$0.00 |
| 83880 |
|
14 |
12 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14 |
13 |
$0.00 |
| 87088 |
|
13 |
12 |
$0.00 |
| 83540 |
|
26 |
26 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
63 |
49 |
$0.00 |
| 84466 |
|
24 |
24 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
39 |
38 |
$0.00 |